VEGFA and neoplasm: In conclusion, we have demonstrated differences in the ability of anti-VEGF therapy to affect tumor vasculature and modulate immune cell infiltration, intra-tumoral and serum cytokine levels depending on the mechanism of VEGF inhibition.